Acute pancreatitis with dipeptidyl peptidase-4 (DPP4) inhibitor or fulminant type 1 diabetes?

Diabetes Metab. 2018 Feb;44(1):95-96. doi: 10.1016/j.diabet.2017.03.010. Epub 2017 May 5.

¹ Department of Diabetology, Assistance publique-Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, 75013 Paris, France; Institute of Cardiometabolism and Nutrition, 75013 Paris, France; UMR S1166, Pierre-and-Marie-Curie University-Paris VI, 75013 Paris, France. Electronic address: amouyal.chloe@gmail.com.
² Department of Gastroenterology/Pancreatology, Assistance publique-Hôpitaux de Paris (AP-HP), Beaujon Hospital, 92110 Clichy, France; DHU UNITY, Denis Diderot University-Paris VII, 92110 Paris, France.
³ Department of Diabetology, Assistance publique-Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, 75013 Paris, France; Institute of Cardiometabolism and Nutrition, 75013 Paris, France; UMR S1166, Pierre-and-Marie-Curie University-Paris VI, 75013 Paris, France.
⁴ Department of Diabetology, Assistance publique-Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, 75013 Paris, France; Institute of Cardiometabolism and Nutrition, 75013 Paris, France; UMR S938, Pierre-and-Marie-Curie University-Paris VI, 75006 Paris, France.

No abstract available

Keywords: DPP4 inhibitor; Fulminant diabetes; Insulin deficiency; Pancreatitis.

Publication types